Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

NovaBay Pharmaceuticals, Inc. (NBY)

2.29   0.27 (13.37%) 01-27 15:59
Open: 1.98 Pre. Close: 2.02
High: 2.31 Low: 1.98
Volume: 100,762 Market Cap: 4(M)

Technical analysis

as of: 2023-01-27 4:46:31 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 3.1     One year: 3.62
Support: Support1: 1.78    Support2: 1.24
Resistance: Resistance1: 2.66    Resistance2: 3.1
Pivot: 2.16
Moving Average: MA(5): 2.16     MA(20): 2.12
MA(100): 3.06     MA(250): 6.54
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 39.3     %D(3): 41.7
RSI: RSI(14): 55.4
52-week: High: 12.94  Low: 0.18
Average Vol(K): 3-Month: 71 (K)  10-Days: 66 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ NBY ] has closed below upper band by 27.3%. Bollinger Bands are 66.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.31 - 2.33 2.33 - 2.34
Low: 1.95 - 1.97 1.97 - 1.98
Close: 2.26 - 2.29 2.29 - 2.31

Company Description

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Headline News

Wed, 25 Jan 2023
Niobay Metals Provides Update on Metallurgical Progress at the ... - Junior Mining Network

Tue, 17 Jan 2023
PhaseOne Health and NovaBay Pharmaceuticals to Expand ... - Business Wire

Fri, 30 Dec 2022
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here ... - Investing.com UK

Wed, 30 Nov 2022
Healthcare Stocks Making Moves Wednesday: HZNP, CHEK, CGEN, AVDL, CNSP, ONCS, NBY, XFOR - InvestorsObserver

Wed, 16 Nov 2022
NovaBay Pharmaceuticals (NBY) Stock: 1-For-35 Reverse Split Goes Into Effect - Pulse 2.0

Tue, 15 Nov 2022
NBY stock falls as company announces reverse stock split (NYSE ... - Seeking Alpha

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 45 (M)
Shares Float 35 (M)
% Held by Insiders 21.1 (%)
% Held by Institutions 2.6 (%)
Shares Short 2,080 (K)
Shares Short P.Month 1,940 (K)

Stock Financials

EPS -0.18
EPS Est Next Qtl -0.03
EPS Est This Year -0.47
EPS Est Next Year -0.1
Book Value (p.s.) 0.2
Profit Margin (%) -96.8
Operating Margin (%) -96.9
Return on Assets (ttm) -31.7
Return on Equity (ttm) -63.9
Qtrly Rev. Growth -15.2
Gross Profit (p.s.) 0.13
Sales Per Share 0.17
EBITDA (p.s.) -0.17
Qtrly Earnings Growth 0
Operating Cash Flow -6 (M)
Levered Free Cash Flow -3 (M)

Stock Valuations

PE Ratio -13.24
PEG Ratio 0
Price to Book value 10.9
Price to Sales 13.42
Price to Cash Flow -16.3

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.